Mutant prevention concentration of ciprofloxacin, enrofloxacin and nalidixic acid against Campylobacter jejuni

Int J Antimicrob Agents. 2008 May;31(5):500-2. doi: 10.1016/j.ijantimicag.2008.01.012. Epub 2008 Mar 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Campylobacter Infections / microbiology
  • Campylobacter jejuni / drug effects*
  • Campylobacter jejuni / genetics
  • Campylobacter jejuni / isolation & purification
  • Ciprofloxacin / pharmacology*
  • Drug Resistance, Bacterial / genetics*
  • Enrofloxacin
  • Fluoroquinolones / pharmacology*
  • Humans
  • Microbial Sensitivity Tests
  • Mutation / drug effects*
  • Nalidixic Acid / pharmacology*
  • Poultry

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Nalidixic Acid
  • Enrofloxacin
  • Ciprofloxacin